For decades, researchers and government agencies have had their eyes on diversity in clinical trials. On April 13, The U.S. Food and Drug Administration issued a draft guidance recommending that...
Read More
At 20/20 Onsite, we pride ourselves on providing excellent customer service and a great patient experience. As Clinical Trial Manager, Pamela Tomic plays a pivotal role in our team’s ability to build...
Read More
COVID-19 has forever altered the future of clinical research, and WCG Clinical suggests that clinical research sites have felt the impact most of all. In an effort to support high-quality clinical...
Read More
Dr. Peter Kaiser is a Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine and a leading clinical researcher of retinal disorders. With contributions to 7 textbooks, 30 book...
Read More
Pharma Intelligence recently published a white paper titled “Rare Disease Trial Strategies” that piqued our team’s interest in how we may be able to help sponsors, CROs, and sites address some of the...
Read More
A recent study by WCG highlighted some of the top post-pandemic clinical trial enrollment challenges sites and sponsors are facing in 2022. Not surprisingly, COVID-19 has completely altered the way...
Read More
Rajat Agrawal, MD, MS is an ophthalmologist and retina specialist with over 25 years of experience between academia and industry. He has been published in leading ophthalmology journals, invited to...
Read More